Sun Pharma defies volatility with $3.2bn jumbo
GlobalCapital, is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023
Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Sun Pharma defies volatility with $3.2bn jumbo

Pharmaceutical 230x150

Daiichi Sankyo Company has exited India’s Sun Pharmaceutical Industries through a jumbo Rp200bn ($3.2bn) block, pricing one of the largest ever ECM deals in the country. An extensive wall crossing process over the weekend helped pave the way for the transaction, which saw a roaring finish despite turbulent market conditions.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login